Russell J. Cox

2012 - Jazz Pharmaceuticals

In 2012, Russell J. Cox earned a total compensation of $3.9M as Executive Vice President and Chief Operating Officer at Jazz Pharmaceuticals, a 214% increase compared to previous year.

Compensation breakdown

Non-Equity Incentive Plan$300,000
Option Awards$1,619,569
Salary$379,250
Stock Awards$1,639,047
Other$1,629
Total$3,939,495

Cox received $1.6M in stock awards, accounting for 42% of the total pay in 2012.

Cox also received $300K in non-equity incentive plan, $1.6M in option awards, $379.3K in salary and $1.6K in other compensation.

Rankings

In 2012, Russell J. Cox's compensation ranked 1,677th out of 11,487 executives tracked by ExecPay. In other words, Cox earned more than 85.4% of executives.

ClassificationRankingPercentile
All
1,677
out of 11,487
85th
Division
Manufacturing
602
out of 4,253
86th
Major group
Chemicals And Allied Products
136
out of 1,198
89th
Industry group
Drugs
74
out of 920
92nd
Industry
Pharmaceutical Preparations
62
out of 700
91st
Source: SEC filing on June 10, 2015.

Cox's colleagues

We found four more compensation records of executives who worked with Russell J. Cox at Jazz Pharmaceuticals in 2012.

2012

Bruce Cozadd

Jazz Pharmaceuticals

Chief Executive Officer

2012

Suzanne Hooper

Jazz Pharmaceuticals

General Counsel

2012

Kathryn Falberg

Jazz Pharmaceuticals

Chief Financial Officer

2012

Jeffrey Tobias

Jazz Pharmaceuticals

Chief Medical Officer

News

You may also like